Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADI vs MRNA✓SelectedUSD · MRNAADI vs MRNA performance historyLatest closeAs of-1.19%11/19
Stock and ETF performance explorer

ADI vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+115.2%
MRNA return
+159.5%
Excess return
-44.4%
Maximum drawdown
-32.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.2%+1.3%-2.5%-1.2%
7D-7.8%-13.8%+6.1%-7.1%
30D-4.9%-17.7%+12.7%-4.1%
3M+1.4%+14.3%-12.9%+0.4%
6M-8.4%+336.0%-344.4%-22.4%
YTD+40.4%+575.9%-535.5%+7.4%
1Y+64.6%+724.4%-659.8%+20.4%
All+115.2%+159.5%-44.4%+87.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling